Antibiotic Research UK launches small research grants programme
Charity will award grants for research projects into antibiotics and antibiotic resistance
13th April 2021
Charity will award grants for research projects into antibiotics and antibiotic resistance
13th April 2021
Cancer experts urge the government to address funding gaps for high-precision radiotherapy
13th April 2021
Self-reported recovery was three days shorter for patients receiving inhaled budesonide
13th April 2021
Newly accepted medicines include treatments for multiple myeloma and severe migraine
13th April 2021
The 2021 Clinical Researcher of the Year – The Americas competition is reaching out to the very best in the industry to take the next step and claim gold.
12th April 2021
Why innovation and continued virtual engagement is key to the future success of the med tech industry
The key three cybersecurity concerns for the pharmaceutical industry in 2021
The next generation of digitised collaborative and shared primary care services
Cost, participation, and virtual trials – the three challenges facing clinical organisations
Amgen v Sanofi: narrowing the scope of protection for antibody inventions?
MAGAZINE EXCLUSIVEIs blockchain the answer to protecting against counterfeits and medicines shortages?
MAGAZINE EXCLUSIVEWhat’s next for account management?
OVID Health founder Jenny Ousbey discusses the pandemic, patient advocacy and the Patient Partnership Index
Samantha Dawson details her experiences living with HIV
Gilead Sciences’ global patient engagement lead and former HIV nurse specialist Geraldine Reilly explores today’s fight against the virus – as TV series It’s A Sin brings back memories of working on the frontline during the AIDS epidemic of the 1980s and 1990s
Abbott’s Dr Nick West talks to PharmaTimes about going beyond intervention to improve the care of cardiovascular patients in the UK
Taking a look at the recent dispute between the EU Commission and AstraZeneca over the ins and outs of its contract, Stuart Evans, commercial litigation expert and partner at law firm BLM, examines what this could represent for EU/UK cross-border pharma relations
The global COVID pandemic has highlighted the need for expert leadership in global healthcare. Oxford University is rising to the challenge, pulling together specialists from business and medical departments to launch an MSc in Global Healthcare Leadership
Ipsen Pharmaceuticals’ Global Digital Health Partnerships Lead, Dr Myles Furnace, discusses the company’s new partnership with digital health specialists Mendelian, which aims to improve the speed of diagnosis of rare diseases
ICON's Michael Pellegrino outlines research looking at patient involvement in journal review processes
Imaginatively designed content combined with patient insights delivers campaigns that inspire behaviour change
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW